HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wayne Tsuji Selected Research

Etanercept (Enbrel)

6/2010Patient-reported outcomes in a randomized trial of etanercept in psoriatic arthritis.
4/2008Rapid and sustained improvement in health-related quality of life and utility for 72 weeks in patients with ankylosing spondylitis receiving etanercept.
7/2007A placebo-controlled, randomized, double-blinded study evaluating the safety of etanercept in patients with rheumatoid arthritis and concomitant comorbid diseases.
4/2006Continued inhibition of radiographic progression in patients with psoriatic arthritis following 2 years of treatment with etanercept.
7/2004Etanercept treatment of psoriatic arthritis: safety, efficacy, and effect on disease progression.
11/2003Recombinant human tumor necrosis factor receptor (etanercept) for treating ankylosing spondylitis: a randomized, controlled trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Wayne Tsuji Research Topics

Disease

6Rheumatoid Arthritis
01/2018 - 11/2003
4Psoriatic Arthritis
06/2010 - 11/2003
2Ankylosing Spondylitis
04/2008 - 11/2003
2Disease Progression
04/2006 - 07/2004
1Nasopharyngitis
12/2019
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
08/2015
1Pain (Aches)
06/2010
1Infections
07/2007
1Lung Diseases (Lung Disease)
07/2007
1Arthritis (Polyarthritis)
03/2007
1Psoriasis (Pustulosis Palmaris et Plantaris)
07/2004
1Injection Site Reaction
11/2003
1Respiratory Tract Infections (Respiratory Tract Infection)
11/2003
1Accidental Injuries
11/2003

Drug/Important Bio-Agent (IBA)

6Etanercept (Enbrel)FDA Link
06/2010 - 11/2003
3DenosumabFDA Link
05/2010 - 05/2008
1AMG-714IBA
12/2019
1AMG623 peptibodyIBA
08/2015
1ametantrone (HAQ)IBA
06/2010
1GlucocorticoidsIBA
05/2010
1Diphosphonates (Bisphosphonates)IBA
05/2010
1Methotrexate (Mexate)FDA LinkGeneric
05/2008
1Anti-Bacterial Agents (Antibiotics)IBA
07/2007
1Acute-Phase Proteins (Acute-Phase Protein)IBA
03/2007
1CytokinesIBA
03/2007
1Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
11/2003

Therapy/Procedure

2Therapeutics
04/2008 - 03/2007
1Genomic Medicine
01/2018